The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis

Alberto Riñon1 Merck Serono S.A. – Geneva, Switzerland, a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, GermanyCorrespondence[email protected]

Mandy Buch2 GfK Healthcare, London, UK

Derek Holley2 GfK Healthcare, London, UK

Elisabetta Verdun1 Merck Serono S.A. – Geneva, Switzerland, a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany

Pages 629-643 | Published online: 28 Dec 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BennettJLStuveOUpdate on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsClin Neuropharmacol20093212113219483479
PubMed Web of Science ®Google Scholar
McDonaldWIRelapse, remission, and progression in multiple sclerosisN Engl J Med20003431486148711078776
PubMed Web of Science ®Google Scholar
MurrayTJDiagnosis and treatment of multiple sclerosisBMJ200633252552716513709
PubMed Web of Science ®Google Scholar
CompstonAConfavreuxCLassmannHMcAlpine’s Multiple Sclerosis4th edPhiladelphia, PAChurchill Livingstone2006
Google Scholar
ConfavreuxCVukusicSMoreauTAdeleinePRelapses and progression of disability in multiple sclerosisN Engl J Med20003431430143811078767
PubMed Web of Science ®Google Scholar
WeinshenkerBGBassBRiceGPThe natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disabilityBrain1989112Pt 11331462917275
PubMed Web of Science ®Google Scholar
World Health OrganizationAdherence to long-term therapies: evidence for action Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.htmlAccessed August 21, 2011
Google Scholar
LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivationExpert Opin Drug Deliv20096995100219637982
PubMed Web of Science ®Google Scholar
TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol200925656857619444532
PubMed Web of Science ®Google Scholar
HalpernRAgarwalSDembekCBortonLLopez-BresnahanMComparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysisPatient Prefer Adherence20115738421423591
PubMed Web of Science ®Google Scholar
TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther201128516121153000
PubMed Web of Science ®Google Scholar
Al-SabbaghABennetRKozmaCMeleticheDMedication gaps in disease-modifying therapy for multiple sclerosis are associated with an increased risk of relapse: findings from a national managed care databaseJ Neurol2008255Suppl 2S79
Google Scholar
UitdehaagBConstantinescuCCornelissePImpact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up studyTher Adv Neurol Disord2011431421339904
PubMedGoogle Scholar
TremlettHLOgerJInterrupted therapy: stopping and switching of the beta-interferons prescribed for MSNeurology20036155155412939437
PubMed Web of Science ®Google Scholar
O’RourkeKEHutchinsonMStopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patternsMult Scler200511465015732266
PubMed Web of Science ®Google Scholar
Multiple Sclerosis International FederationAtlas of MS Database2007 Available from: http://www.atlasofms.org/query.aspx?pq=yes&s=1&q=3&r=Global&year=2007Accessed August 21, 2011
Google Scholar
TremlettHVander MeiIPittasFAdherence to the immuno-modulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing dosesPharmacoepidemiol Drug Saf20081756557618395883
PubMed Web of Science ®Google Scholar
Multiple Sclerosis International FederationMS: the Guide to Treatment and Management2008 Available from: http://www.msif.org/en/resources/msif_resources/msif_publications/ms_the_guide_to_treatment_and_management/treatments_affecting_longterm_course_of_disease/index.htmlAccessed August 21, 2011
Google Scholar
PortaccioEZipoliVSiracusaGSorbiSAmatoMPLong-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosisEur Neurol20085913113518057899
PubMed Web of Science ®Google Scholar
RiJPorcelJTellezNFactors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosisMult Scler20051130630915957512
PubMed Web of Science ®Google Scholar
OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date